QUEST DIAGNOSTICS INC (DGX)

US74834L1008 - Common Stock

136.94  +1.3 (+0.96%)

After market: 136.94 0 (0%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

QUEST DIAGNOSTICS INC

NYSE:DGX (5/7/2024, 7:04:00 PM)

After market: 136.94 0 (0%)

136.94

+1.3 (+0.96%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Providers & Services
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap15.21B
Shares
PE15.72
Fwd PE14.42
Dividend Yield2.2%
Analysts
IPO
Stock Screener Links
Screen Image

New York Stock Exchange, Inc. Stock Screener

Find more stocks on New York Stock Exchange, Inc.

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

DGX Daily chart

Company Profile

Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information and services. The company is headquartered in Secaucus, New Jersey and currently employs 40,000 full-time employees. The firm operates through the DIS segment, which provides diagnostic information services to a range of customers, including patients, clinicians, hospitals, independent delivery networks (IDNs), health plans, employers, consumers, and accountable care organizations (ACOs). The company is also engaged in two business operations, Diagnostic Information Services, which develops and delivers diagnostic information services that provide insights to a range of customers, and the Diagnostic Solutions group includes its risk assessment services business, which offers solutions for insurers, and its healthcare information technology business, which offers solutions for healthcare providers. The Company’s brands include the Quest Diagnostics brand, AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum. The firm also offers full-service laboratory services, which serves patients and physicians in Pennsylvania and Ohio.

Company Info

QUEST DIAGNOSTICS INC

500 Plaza Drive

Secaucus NEW JERSEY 07094

P: 19735202700

CEO: Stephen H. Rusckowski

Employees: 40000

Website: https://www.questdiagnostics.com/

DGX News

News Image15 hours ago - Quest DiagnosticsQuest Diagnostics to Speak at the 2024 Leerink Partners Healthcare Crossroads Conference

/PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that Jim Davis, Chairman, CEO and President,...

News Image2 days ago - Quest DiagnosticsQuest Diagnostics Names Murali Balakumar Senior Vice President and Chief Information and Digital Officer

/PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, announced today that Murali Balakumar, a veteran...

News Image7 days ago - Quest DiagnosticsQuest Diagnostics to Acquire PathAI Diagnostics to Accelerate AI and Digital Pathology Adoption in Cancer Diagnosis; Forms Licensing Agreements with PathAI

/PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, and PathAI, a global provider of artificial intelligence-powered...

News Image8 days ago - AB NewswireIntelligent Bio Solutions Screening Technologies Poised to Disrupt The Healthcare Sector: INBS, LH, ABT, DGX
News Image9 days ago - ChartmillMonday's session: top gainers and losers in the S&P500 index

Top movers analysis one hour before the close of the markets of S&P500 on 2024-04-29: top gainers and losers in today's session.

News Image9 days ago - Market News VideoNotable Monday Option Activity: TDG, DGX, DLTR

DGX Twits

Here you can normally see the latest stock twits on DGX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example